Search
Search Results
##search.searchResults.foundPlural##
-
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1268PDF: 877HTML: 317 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5164PDF: 1324HTML: 2747Cover letter: 194 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1811PDF: 809HTML: 10235Figures 1,2,3: 175 -
SOLITARY PLASMACYTOMA
3868PDF: 2177HTML: 1223fIGURES 1,2: 215 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4130PDF: 1951HTML: 1765 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2094PDF: 1528HTML: 286 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3898PDF: 1480HTML: 8513 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1300PDF: 1014HTML: 122 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1813PDF: 821HTML: 227 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1315PDF: 913HTML: 303 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2584PDF: 747HTML: 2298 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3998PDF: 1055HTML: 3595Untitled: 177Cneo. Fig.1: 114Untitled: 105Untitled: 126Untitled: 133 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2199PDF: 806HTML: 1630Figure 1: 183Table 1: 210 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1850HTML: 1454PDF: 1088 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7975PDF: 4147HTML: 7371 -
SICKLE CELL ANAEMIA AND MALARIA
11455PDF: 7011HTML: 23887Figures Malaria and SCK: 214 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
938PDF: 505Html: 144Suppl. Files: 174 -
The diagnostic pitfalls of mucormycosis
925PDF: 717HTML: 251 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2254PDF: 762HTML: 1275 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6848PDF: 3648HTML: 753 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2029PDF: 1053HTML: 721Figure 1: 155Figure 2: 170 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
0PDF: 0HTML: 0 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2212PDF: 1497HTML: 267 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1186PDF: 837HTML: 3363 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2461HTML: 272PDF: 873 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1946PDF: 1166HTML: 268 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2134PDF: 1697HTML: 378 -
PROPHYLAXIS OF MALARIA
3018PDF: 1021HTML: 17825Figures SChwartz: 165 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1593PDF: 1218HTML: 259 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1571PDF: 848HTML: 1032Picture 1: 168







